About GreenLight Biosciences
GreenLight Biosciences is a company based in Lexington (United States) founded in 2008 by Andrey Zarur. GreenLight Biosciences has raised $225.05 million across 13 funding rounds from investors including ARE, United States Department of Agriculture and Khosla Ventures. The company has 287 employees as of December 31, 2022. GreenLight Biosciences offers products and services including Calantha and Norroa. GreenLight Biosciences operates in a competitive market with competitors including Veritas Genetics, Kailos, Yunhu Technology Group, ARCpoint Labs and Genesis Healthcare, among others.
- Headquarter Lexington, United States
- Employees 287 as on 31 Dec, 2022
- Founders Andrey Zarur
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Greenlight Biosciences, Inc.
-
Annual Revenue
$6.78 M (USD)325as on Dec 31, 2022
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$225.05 M (USD)
in 13 rounds
-
Latest Funding Round
$25 M (USD), Post-IPO
Apr 07, 2025
-
Investors
ARE
& 27 more
-
Employee Count
287
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GreenLight Biosciences
GreenLight Biosciences offers a comprehensive portfolio of products and services, including Calantha and Norroa.
Controls Colorado Potato Beetles in potato crops effectively and sustainably.
Protects honey bees from Varroa destructor mites through RNA-based solutions.
People of GreenLight Biosciences
Unlock access to complete
Funding Insights of GreenLight Biosciences
GreenLight Biosciences has successfully raised a total of $225.05M across 13 strategic funding rounds. The most recent funding activity was a Post-IPO round of $25 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in GreenLight Biosciences
GreenLight Biosciences has secured backing from 28 investors, including institutional and venture fund investors. Prominent investors backing the company include ARE, United States Department of Agriculture and Khosla Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Stage agnostic venture capital firm
|
Locked | Locked | Locked | |
|
Investments are directed to food, agribusiness, and commodities sectors.
|
Locked | Locked | Locked | |
|
VC firm that does early stage investments in the US
|
Locked | Locked | Locked |
Investor details for GreenLight Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GreenLight Biosciences
Investment portfolio details for GreenLight Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GreenLight Biosciences
Detailed financials for GreenLight Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Greenlight Biosciences Comparisons
Peer comparison for GreenLight Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GreenLight Biosciences
GreenLight Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Veritas Genetics, Kailos, Yunhu Technology Group, ARCpoint Labs and Genesis Healthcare, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genetic testing products for health risks and traits are offered.
|
|
| Locked | Locked | Locked |
Provider of consumer-based genetic testing services
|
|
| Locked | Locked | Locked |
DNA testing services are provided via an online platform.
|
|
| Locked | Locked | Locked |
Provider of genetic testing services
|
|
| Locked | Locked | Locked |
Provider of consumer kits and genomic services for researchers
|
Detailed competitors of GreenLight Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Greenlight Biosciences
Complete news archive for GreenLight Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GreenLight Biosciences
GreenLight Biosciences was founded in 2008 and raised its 1st funding round 1 year after it was founded.
GreenLight Biosciences is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
Andrey Zarur is the current CEO of GreenLight Biosciences. They have also founded this company.
GreenLight Biosciences is a funded company, having raised a total of $225.05M across 13 funding rounds to date.
As of Dec 31, 2022, the latest employee count at GreenLight Biosciences is 287.
Annual revenue of GreenLight Biosciences is $6.78M as on Dec 31, 2022.
GreenLight Biosciences was founded in 2008 and is based in Lexington, United States. A platform for RNA-based products is provided for the life science industry. Applications include vaccine development, antibody therapies, pandemic preparation, crop management, plant protection, and support for bee and pollinator health. Operations focus on biotechnology solutions across agriculture and human health sectors.
GreenLight Biosciences's top competitors include Veritas Genetics, ARCpoint Labs and Genesis Healthcare.
GreenLight Biosciences offers Calantha and Norroa.
GreenLight Biosciences has 28 investors. Key investors include ARE, United States Department of Agriculture, Khosla Ventures, BNP Paribas Asset Management, and Greenlight Re.